Rondo therapeutics. Rondo Therapeutics. An immuno-oncology-focused biotech based in San Francisco, USA, that emerged from stealth mode in March 2022 with its announcement of an oversubscribed $67 million Series A round of funding. Rondo Therapeutics 11 months Scientist Jan 2023 - Present3 months Hayward, California, United States Associate Scientist May 2022 - Jan 20239 months Alameda, CA As first member of the protein...February 2022 Website https://rondotx.com/ Rondo is committed to advancing the field of immuno-oncology, with a focus on treating solid tumors that fail to respond to current …Other big Series A rounds went to Pheast Therapeutics, and Rondo Therapeutics, two immuno-oncology startups. 2. Crypto So far, 2022 has been a bad year for cryptocurrency valuations, but a pretty good one for crypto-related venture funding. Among Series A rounds, crypto was a commonly recurring theme.02-03-2022 Print. Rondo Therapeutics, a new immune-oncology-focused biotech based in San Francisco, USA, today emerged from stealth mode with its announcement of an oversubscribed $67 million Series A round of funding. Proceeds will support the continued development of Rondo’s pre-clinical pipeline as the company advances its lead bispecific ...Associate Scientist. Rondo Therapeutics. May 2022 - Jan 20239 months. Alameda, CA. As first member of the protein sciences team, I will be responsible for protein purification method development ...Mar 2, 2022 · Rondo Therapeutics launched Wednesday with a $67 million Series A and backing from J&J, among others, to build out its platform of next-gen T cell engagers and bispecific antibodies targeting... Rondo Therapeutics, a new immune-oncology-focused biotech based in San Francisco, USA, today emerged from stealth mode with its announcement of an oversubscribed $67 million Series A round of funding.Rondo Therapeutics | 941 followers on LinkedIn. Exploring new frontiers in cancer therapy. | At Rondo Therapeutics we believe that our success as a company starts with building a culture based...Contact Information Headquarters San Francisco, California, United States Rondo Therapeutics Profile and History Rondo Therapeutics is a company that operates in the Biotechnology industry. It employs 6-10 people and has $1M-$5M of revenue. The company is headquartered in San Francisco, California. Popular Searches Rondo Therapeutics Rondo Therapeutics, a biopharmaceutical company, has raised $67 million in Series A funding. Iris Dorbian - 2 March 2022. Share A-A + 100%. Rondo Therapeutics, a biopharmaceutical company, has raised $67 million in Series A funding. Red Tree Venture Capital and Canaan Partners led the round. Source: Press Release . TAGS;Rondo is committed to advancing the field of immuno-oncology, with a focus on treating solid tumors that fail to respond to current therapies. Rondo’s solution is to create a new class of bispecific antibodies that safely engage the immune system to initiate and sustain a robust anti-tumor response.Rondo Therapeutics is a privately held biotechnology company committed to advancing the field of immuno-oncology with a focus on treating solid tumors that fail to respond to current therapies. Our solution is to create a new class of bispecific antibodies that safely engage the immune system to initiate and sustain a robust anti-tumor response.Rondo Therapeutics is a therapeutic antibody discovery and development that creates novel bispecific antibodies that activate the immune system to fight cancer. The company was founded in 2021 and is headquartered in Hayward, California. Industries Biotechnology, Health Care Headquarters Hayward, United States Stage Series A Employees 11-50 LinksRondo Therapeutics: Based on San Francisco, Rondo is developing a new class of bispecific antibodies that safely engage the immune system to initiate and sustain a robust anti-tumor response. In March, the company raised $67 million in a Series A financing round to support its immune stimulatory bispecific antibody program.Jan 14, 2020 · Rondo Therapeutics, Inc. Overview Rondo Therapeutics, Inc. filed as a Statement & Designation By Foreign Corporation in the State of California on Tuesday, January 14, 2020 and is approximately three years old, according to public records filed with California Secretary of State. SAN FRANCISCO BAY AREA, Calif., Sept. 7, 2022 /PRNewswire/ -- Rondo Therapeutics, a privately-held biotechnology company advancing next-generation immuno-oncology platforms, announces the...Associate Scientist. Rondo Therapeutics. May 2022 - Jan 20239 months. Alameda, CA. As first member of the protein sciences team, I will be responsible for protein purification method development ...Jan 14, 2020 · Rondo Therapeutics, Inc. Overview Rondo Therapeutics, Inc. filed as a Statement & Designation By Foreign Corporation in the State of California on Tuesday, January 14, 2020 and is approximately three years old, according to public records filed with California Secretary of State. Rondo Therapeutics is a therapeutic antibody discovery and development that creates novel bispecific antibodies that activate the immune system to fight cancer. The company was founded in 2021 and is headquartered in Hayward, California. Industries Biotechnology, Health Care Headquarters Hayward, United States Stage Series A Employees 11-50 Links zerojedgeempirixglamstar limited SAN FRANCISCO, March 2, 2022 /PRNewswire/ -- Rondo Therapeutics, a biopharmaceutical company advancing a next-generation immuno-oncology platform for …Rondo Therapeutics is exploring new frontiers in cancer therapy. We are committed to advancing the field of immuno-oncology, with a focus on treating solid tumors that fail to …Rondo Therapeutics 11 months Scientist Jan 2023 - Present3 months Hayward, California, United States Associate Scientist May 2022 - Jan 20239 months Alameda, CA As first member of the protein... cal fresco co Rondo Therapeutics 11 months Scientist Jan 2023 - Present3 months Hayward, California, United States Associate Scientist May 2022 - Jan 20239 months Alameda, CA As first member of the protein... Oct 6, 2022 · Rondo Therapeutics: Developing new class of bispecific antibodies that safely engage the immune system to initiate and sustain a robust anti-tumor response. Sardona Therapeutics: Developing... despir logistics Rondo Therapeutics is a therapeutic antibody discovery and development that creates novel bispecific antibodies that activate the immune system to fight cancer. The company was founded in 2021 and is headquartered in Hayward, California. Industries Biotechnology, Health Care Headquarters Hayward, United States Stage Series A Employees 11-50 LinksPrivate Company. "Rondo Therapeutics is exploring new frontiers in cancer therapy. We are committed to advancing the field of immuno-oncology, with a focus on treating solid tumors that fail to respond to current therapies. Rondo's solution is to create a new class of bispecific antibodies that safely engage the immune system to initiate and ...Rondo Therapeutics is exploring new frontiers in cancer therapy. We are committed to advancing the field of immuno-oncology, with a focus on treating solid tumors that fail to respond to current therapies. amazing mailSep 7, 2022 · Rondo Therapeutics, a privately-held biotechnology company advancing next-generation immuno-oncology platforms, announces the addition of Carolyn Bertozzi, Ph.D., to its Scientific Advisory Board. Sep 7, 2022 · Rondo Therapeutics, a privately-held biotechnology company advancing next-generation immuno-oncology platforms, announces the addition of Carolyn Bertozzi, Ph.D., to its Scientific Advisory Board. Apr 12, 2022 · Top 10 companies with the highest series A funding We have compiled the top 10 companies with the highest Series A funding rounds in the following list. A short profile description is given for those unfamiliar with their startup for each company. Moreover, the amount of funding in this round is also disclosed. Let us get started! 1. FTX US elh management Rondo Therapeutics | 941 followers on LinkedIn. Exploring new frontiers in cancer therapy. | At Rondo Therapeutics we believe that our success as a company starts with building a culture based...Dr. Edwards currently is a board member at Excellergy, Sardona Therapeutics, and Rondo Therapeutics. He received a Ph.D. in biochemistry and biophysics from the University of North Carolina at Chapel Hill and holds a B.S. from the University of Vermont. Rondo Therapeutics 1 year 1 month Director, Preclinical biology Jan 2023 - Present5 months Hayward, California, United States Senior Scientist II, Preclinical Biology May 2022 - Jan 20239 months... Rondo Therapeutics: Based on San Francisco, Rondo is developing a new class of bispecific antibodies that safely engage the immune system to initiate and sustain a robust anti-tumor response. In March, the company raised $67 million in a Series A financing round to support its immune stimulatory bispecific antibody program.Venture capitalists have invested $67 million in Rondo Therapeutics Inc., a cancer drug developer led by entrepreneurs who previously helped start successful biotechnology company Teneobio Inc ...Legal Name Rondo Therapeutics, Inc. Company Type For Profit. Rondo Therapeutics is a therapeutic antibody discovery and development that creates novel bispecific antibodies that activate the immune system to fight cancer. The company was founded in 2021 and is headquartered in Hayward, California.Rondo Therapeutics, Inc. Overview Rondo Therapeutics, Inc. filed as a Statement & Designation By Foreign Corporation in the State of California on Tuesday, January 14, 2020 and is approximately three years old, according to public records filed with California Secretary of State.Rondo Therapeutics launched Wednesday with a $67 million Series A and backing from J&J, among others, to build out its platform of next-gen T cell engagers and bispecific antibodies targeting ... next now May 29, 2023 · Explore Rondo Therapeutics, Inc. with its drug pipeline, therapeutic area, technology platform, 4 news. Sep 7, 2022 · Rondo Therapeutics, a privately-held biotechnology company advancing next-generation immuno-oncology platforms, announces the addition of Carolyn Bertozzi, Ph.D., to its Scientific Advisory Board. tabnam Rondo Therapeutics Follow Founded in 2020 Private Company "Rondo Therapeutics is exploring new frontiers in cancer therapy. We are committed to advancing the field of immuno-oncology, with a focus on treating solid tumors that fail to …Rondo Therapeutics is a biopharmaceutical company exploring new frontiers in cancer therapy. Rondo is committed to advancing the field of immuno-oncology, with a focus on treating solid tumors that fail to respond to current therapies. dnb. Rondo Therapeutics 1 year 1 month Director, Preclinical biology Jan 2023 - Present5 months Hayward, California, United States Senior Scientist II, Preclinical Biology May 2022 - Jan 20239 months...Mar 2, 2022 · Text. Venture capitalists have invested $67 million in Rondo Therapeutics Inc., a cancer drug developer led by entrepreneurs who previously helped start successful biotechnology company Teneobio Inc. Rondo Therapeutics | 970 seguidores en LinkedIn. Exploring new frontiers in cancer therapy. | At Rondo Therapeutics we believe that our success as a company starts with building a culture based on teamwork, trust, career growth, and a sense of fun. If you are a fearless scientist driven to make new discoveries and you value collaboration, respect, …Legal Name Rondo Therapeutics, Inc. Company Type For Profit. Rondo Therapeutics is a therapeutic antibody discovery and development that creates novel bispecific antibodies that activate the immune system to fight cancer. The company was founded in 2021 and is headquartered in Hayward, California. shed dran motel Associate Scientist. Rondo Therapeutics. May 2022 - Jan 20239 months. Alameda, CA. As first member of the protein sciences team, I will be responsible for protein purification method development ... Rondo Therapeutics raised $67000000 on 2022-03-02 in Series A. Red Tree Venture Capital Red Tree Venture Capital operates as a venture capital firm that focuses on entrepreneurs developing first-in-class.Rondo Therapeutics | 941 followers on LinkedIn. Exploring new frontiers in cancer therapy. | At Rondo Therapeutics we believe that our success as a company starts with building a culture based on teamwork, trust, career growth, and a sense of fun. ira resources Sep 7, 2022 · Rondo Therapeutics is a biopharmaceutical company exploring new frontiers in cancer therapy. Rondo is committed to advancing the field of immuno-oncology, with a focus on treating solid tumors... Dr. Edwards currently is a board member at Excellergy, Sardona Therapeutics, and Rondo Therapeutics. He received a Ph.D. in biochemistry and biophysics from the University of North Carolina at Chapel Hill and holds a B.S. from the University of Vermont.Feb 22, 2022 · Information on valuation, funding, cap tables, investors, and executives for Rondo Therapeutics. Use the PitchBook Platform to explore the full profile. Red Tree Venture Capital was founded in 2020 by Heath Lukatch, Ph.D., and Jennifer Cochran, Ph.D., two experienced life science industry veterans with deep connections to the West Coast academic and biopharma ecosystems. Rondo Therapeutics 1 year 1 month Director, Preclinical biology Jan 2023 - Present5 months Hayward, California, United States Senior Scientist II, Preclinical Biology May 2022 - Jan 20239 months...Rondo Therapeutics is a privately held biotechnology company committed to advancing the field of immuno-oncology with a focus on treating solid tumors that fail to respond to current therapies. Our solution is to create a new class of bispecific antibodies that safely engage the immune system to initiate and sustain a robust anti-tumor response. alloprof Rondo Therapeutics is a therapeutic antibody discovery and development that creates novel bispecific antibodies that activate the immune system to fight cancer. The company was founded in 2021 and is headquartered in Hayward, California. Industries Biotechnology, Health Care Headquarters Hayward, United States Stage Series A Employees 11-50 Links verisim life Sep 21, 2021 · Rondo Therapeutics 10 months Scientist II Apr 2023 - Present2 months San Francisco Bay Area Scientist I Aug 2022 - Mar 20238 months San Francisco Bay Area Working on discovery and engineering of... Jan 14, 2020 · Rondo Therapeutics, Inc. filed as a Statement & Designation By Foreign Corporation in the State of California on Tuesday, January 14, 2020 and is approximately three years old, according to public records filed with California Secretary of State. A corporate filing is called a foreign filing when an existing corporate entity files in a state ... Dr. Edwards currently is a board member at Excellergy, Sardona Therapeutics, and Rondo Therapeutics. He received a Ph.D. in biochemistry and biophysics from the University of North Carolina at Chapel Hill and holds a B.S. from the University of Vermont. SAN FRANCISCO, March 2, 2022 /PRNewswire/ -- Rondo Therapeutics, a biopharmaceutical company advancing a next-generation immuno-oncology platform for … snap finance llc Rondo Therapeutics | 941 followers on LinkedIn. Exploring new frontiers in cancer therapy. | At Rondo Therapeutics we believe that our success as a company starts with building a culture based...Rondo Therapeutics | 941 followers on LinkedIn. Exploring new frontiers in cancer therapy. | At Rondo Therapeutics we believe that our success as a company starts with building a culture based on teamwork, trust, career growth, and a sense of fun. russell welding Rondo is committed to advancing the field of immuno-oncology, with a focus on treating solid tumors that fail to respond to current therapies. Rondo’s solution is to create a new class of bispecific antibodies that safely engage the immune system to initiate and sustain a robust anti-tumor response. Mar 15, 2023 · Rondo Therapeutics is part of the Business Services industry, and located in California, United States. Rondo Therapeutics Location San Francisco, California,United States Description Industry Medical Testing & Clinical Laboratories Healthcare Discover more about Rondo Therapeutics Todd Meyerrose Work Experience and Education Rondo Therapeutics: Based on San Francisco, Rondo is developing a new class of bispecific antibodies that safely engage the immune system to initiate and sustain a robust anti-tumor response. In March, the company raised $67 million in a Series A financing round to support its immune stimulatory bispecific antibody program.Jun 3, 2022 · Rondo Therapeutics Overview Rondo Therapeutics is a therapeutic antibody discovery and development that creates novel bispecific antibodies that activate the immune system to fight cancer. The company was founded in 2021 and is ... Show more Rondo Therapeutics headquarters is in Hayward, California. Rondo Therapeutics is in the sectors of: Biotech. farmers state bank of trimont Rondo Therapeutics raised $67000000 on 2022-03-02 in Series A. Red Tree Venture Capital Red Tree Venture Capital operates as a venture capital firm that focuses on entrepreneurs developing first-in-class.February 2022 Website https://rondotx.com/ Rondo is committed to advancing the field of immuno-oncology, with a focus on treating solid tumors that fail to respond to current therapies. Rondo’s solution is to create a new class of bispecific antibodies that safely engage the immune system to initiate and sustain a robust anti-tumor response.Rondo Therapeutics: Developing new class of bispecific antibodies that safely engage the immune system to initiate and sustain a robust anti-tumor response. Sardona Therapeutics: Developing... magic eden If you're a small business in need of assistance, please contact [email protected]
Associate Scientist. Rondo Therapeutics. May 2022 - Jan 20239 months. Alameda, CA. As first member of the protein sciences team, I will be responsible for protein purification method development ...Rondo Therapeutics is exploring new frontiers in cancer therapy. We are committed to advancing the field of immuno-oncology, with a focus on treating solid tumors that fail to respond to current therapies. potelcom supply inc Rondo Therapeutics is exploring new frontiers in cancer therapy. We are committed to advancing the field of immuno-oncology, with a focus on treating solid tumors that fail to respond to current therapies. Rondo Therapeutics is committed to advancing the field of immuno-oncology, with a focus on treating solid tumors that fail to respond to current therapies. Our solution is to create a new class... Apr 12, 2022 · Top 10 companies with the highest series A funding We have compiled the top 10 companies with the highest Series A funding rounds in the following list. A short profile description is given for those unfamiliar with their startup for each company. Moreover, the amount of funding in this round is also disclosed. Let us get started! 1. FTX US Rondo Therapeutics. An immuno-oncology-focused biotech based in San Francisco, USA, that emerged from stealth mode in March 2022 with its announcement of an oversubscribed $67 million Series A round of funding. Denali Therapeutics is dedicated to defeating neurodegenerative diseases through rigorous therapeutic discovery and development. insphero Sep 7, 2022 · SAN FRANCISCO BAY AREA, Calif., Sept. 7, 2022 /PRNewswire/ -- Rondo Therapeutics, a privately-held biotechnology company advancing next-generation immuno-oncology platforms, announces the... Funding Rounds 1 Total Funding Amount $67M Lead Investors 2 Investors 5 Funding Rondo Therapeutics has raised a total of $67M in funding over 1 round. This was a Series A round raised on Mar 2, 2022. Rondo Therapeutics is funded by 5 investors. SV Health Investors and Johnson & Johnson Innovation – JJDC are the most recent …Rondo Therapeutics: Based on San Francisco, Rondo is developing a new class of bispecific antibodies that safely engage the immune system to initiate and sustain a robust anti-tumor response. In March, the company raised $67 million in a Series A financing round to support its immune stimulatory bispecific antibody program.Mar 2, 2022 · Text. Venture capitalists have invested $67 million in Rondo Therapeutics Inc., a cancer drug developer led by entrepreneurs who previously helped start successful biotechnology company Teneobio Inc. smith cairns ford Denali Therapeutics is dedicated to defeating neurodegenerative diseases through rigorous therapeutic discovery and development.Rondo Therapeutics launched Wednesday with a $67 million Series A and backing from J&J, among others, to build out its platform of next-gen T cell engagers and bispecific antibodies targeting ...Jan 14, 2020 · Rondo Therapeutics, Inc. filed as a Statement & Designation By Foreign Corporation in the State of California on Tuesday, January 14, 2020 and is approximately three years old, according to public records filed with California Secretary of State. A corporate filing is called a foreign filing when an existing corporate entity files in a state ... premier kings inc Rondo Therapeutics is a biopharmaceutical company committed to advancing the field of immuno-oncology, with a focus on treating solid tumors that fail to respond to current therapies. Rondo Therapeutics | 941 followers on LinkedIn. Exploring new frontiers in cancer therapy. | At Rondo Therapeutics we believe that our success as a company starts with building a culture based on teamwork, trust, career growth, and a sense of fun. castlepark investments Feb 3, 2022 · 02-03-2022 Print. Rondo Therapeutics, a new immune-oncology-focused biotech based in San Francisco, USA, today emerged from stealth mode with its announcement of an oversubscribed $67 million Series A round of funding. Proceeds will support the continued development of Rondo’s pre-clinical pipeline as the company advances its lead bispecific ... Rondo Therapeutics, a privately-held biotechnology company advancing next-generation immuno-oncology platforms, announces the addition of Carolyn Bertozzi, Ph.D., to its Scientific Advisory Board.Mar 3, 2022 · Rondo believes bispecifics that engage T cell biology beyond TCR signaling will be more successful against solid tumors than established CD3-based formats. Founded by TeneoBio Inc. alumni Shelley Force Aldred and Nathan Trinklein, Rondo Therapeutics Inc. announced a $67 million series A round Wednesday co-led by Red Tree Venture Capital and ... avellino labRondo Therapeutics, Inc. filed as a Statement & Designation By Foreign Corporation in the State of California on Tuesday, January 14, 2020 and is approximately three years old, according to public records filed with California Secretary of State. A corporate filing is called a foreign filing when an existing corporate entity files in a state ...Legal Name Rondo Therapeutics, Inc. Company Type For Profit. Rondo Therapeutics is a therapeutic antibody discovery and development that creates novel bispecific antibodies that activate the immune system to fight cancer. The company was founded in 2021 and is headquartered in Hayward, California.Rondo Therapeutics is exploring new frontiers in cancer therapy. We are committed to advancing the field of immuno-oncology, with a focus on treating solid tumors that fail to respond to current therapies. tel a rent Feb 9, 2022 · Seismic Therapeutic is a biotechnology company advancing machine learning for immunology drug development. Watertown, Massachusetts, United States 11-50 Series A Private seismictx.com/ 13,182 Highlights Total Funding Amount $101M Contacts 25 Employee Profiles 8 Investors 6 Similar Companies 51 Find More Contacts for Seismic Therapeutic Jun 3, 2022 · Rondo Therapeutics Overview Rondo Therapeutics is a therapeutic antibody discovery and development that creates novel bispecific antibodies that activate the immune system to fight cancer. The company was founded in 2021 and is ... Show more Rondo Therapeutics headquarters is in Hayward, California. Rondo Therapeutics is in the sectors of: Biotech. Rondo Therapeutics | 970 seguidores en LinkedIn. Exploring new frontiers in cancer therapy. | At Rondo Therapeutics we believe that our success as a company starts with building a culture based on teamwork, trust, career growth, and a sense of fun. If you are a fearless scientist driven to make new discoveries and you value collaboration, respect, … abusix Other big Series A rounds went to Pheast Therapeutics, and Rondo Therapeutics, two immuno-oncology startups. 2. Crypto So far, 2022 has been a bad year for cryptocurrency valuations, but a pretty good one for crypto-related venture funding. Among Series A rounds, crypto was a commonly recurring theme.May 29, 2023 · Explore Rondo Therapeutics, Inc. with its drug pipeline, therapeutic area, technology platform, 4 news. Rondo Therapeutics is a biopharmaceutical company committed to advancing the field of immuno-oncology, with a focus on treating solid tumors that fail to respond to current therapies. wing security Mar 02, 2022, 07:00 ET SAN FRANCISCO, March 2, 2022 /PRNewswire/ -- Rondo Therapeutics, a biopharmaceutical company advancing a next-generation immuno-oncology platform for treating solid tumors,...Mar 3, 2022 · Rondo Therapeutics is developing bispecific antibody drugs capable of treating solid tumors, which have eluded this type of cancer therapy. Led by co-founders and Teneobio veterans Shelley Force... Rondo Therapeutics 11 months Scientist Jan 2023 - Present3 months Hayward, California, United States Associate Scientist May 2022 - Jan 20239 months Alameda, CA As first member of the protein... jaccar Mar 02, 2022, 07:00 ET SAN FRANCISCO, March 2, 2022 /PRNewswire/ -- Rondo Therapeutics, a biopharmaceutical company advancing a next-generation immuno-oncology platform for treating solid tumors,...Rondo Therapeutics Follow Founded in 2020 Private Company "Rondo Therapeutics is exploring new frontiers in cancer therapy. We are committed to advancing the field of immuno-oncology, with a focus on treating solid tumors that fail to respond to current therapies.Rondo Therapeutics is exploring new frontiers in cancer therapy. We are committed to advancing the field of immuno-oncology, with a focus on treating solid tumors that fail to respond to current therapies. Chief Development Officer, Rondo Therapeutics. Dr. Katherine Harris is a biopharmaceutical executive who is deeply committed to advancing drug development with scientific rigor that is grounded in a moral imperative to move quickly and efficiently to advance drugs to the clinic, where every day counts to patients in need. deeco rubber company Mar 2, 2022 · Venture capitalists have invested $67 million in Rondo Therapeutics Inc., a cancer drug developer led by entrepreneurs who previously helped start successful biotechnology company Teneobio Inc ... May 29, 2023 · Explore Rondo Therapeutics, Inc. with its drug pipeline, therapeutic area, technology platform, 4 news. basin drilling Red Tree Venture Capital was founded in 2020 by Heath Lukatch, Ph.D., and Jennifer Cochran, Ph.D., two experienced life science industry veterans with deep connections to the West Coast academic and biopharma ecosystems. Rondo Therapeutics is committed to advancing the field of immuno-oncology, with a focus on treating solid tumors that fail to respond to current therapies. Our solution is to create a new class...Contact Information Headquarters San Francisco, California, United States Rondo Therapeutics Profile and History Rondo Therapeutics is a company that operates in the Biotechnology industry. It employs 6-10 people and has $1M-$5M of revenue. The company is headquartered in San Francisco, California. Popular Searches Rondo Therapeutics Funding Rounds 1 Total Funding Amount $67M Lead Investors 2 Investors 5 Funding Rondo Therapeutics has raised a total of $67M in funding over 1 round. This was a Series A round raised on Mar 2, 2022. Rondo Therapeutics is funded by 5 investors. SV Health Investors and Johnson & Johnson Innovation – JJDC are the most recent …Rondo Therapeutics Overview Rondo Therapeutics is a therapeutic antibody discovery and development that creates novel bispecific antibodies that activate the immune system to fight cancer. The company was founded in 2021 and is ... Show more Rondo Therapeutics headquarters is in Hayward, California. Rondo Therapeutics is in the sectors of: Biotech. sequiter Mar 02, 2022, 07:00 ET SAN FRANCISCO, March 2, 2022 /PRNewswire/ -- Rondo Therapeutics, a biopharmaceutical company advancing a next-generation immuno-oncology platform for treating solid tumors,...Rondo Therapeutics | 941 followers on LinkedIn. Exploring new frontiers in cancer therapy. | At Rondo Therapeutics we believe that our success as a company starts with building a culture based on teamwork, trust, career growth, and a sense of fun. 1stfederalofsc Feb 3, 2022 · 02-03-2022 Print. Rondo Therapeutics, a new immune-oncology-focused biotech based in San Francisco, USA, today emerged from stealth mode with its announcement of an oversubscribed $67 million Series A round of funding. Proceeds will support the continued development of Rondo’s pre-clinical pipeline as the company advances its lead bispecific ... Rondo Therapeutics | 941 followers on LinkedIn. Exploring new frontiers in cancer therapy. | At Rondo Therapeutics we believe that our success as a company starts with building a culture based on teamwork, trust, career growth, and a sense of fun. Rondo Therapeutics 11 months Scientist Jan 2023 - Present3 months Hayward, California, United States Associate Scientist May 2022 - Jan 20239 months Alameda, CA As first member of the protein...May 29, 2023 · Explore Rondo Therapeutics, Inc. with its drug pipeline, therapeutic area, technology platform, 4 news. Contact Information Headquarters San Francisco, California, United States Rondo Therapeutics Profile and History Rondo Therapeutics is a company that operates in the Biotechnology industry. It employs 6-10 people and has $1M-$5M of revenue. The company is headquartered in San Francisco, California. Popular Searches Rondo TherapeuticsRondo Therapeutics is committed to advancing the field of immuno-oncology, with a focus on treating solid tumors that fail to respond to current therapies. Our solution is to create a new class... city bank and trust crete ne Rondo Therapeutics 1 year 1 month Director, Preclinical biology Jan 2023 - Present5 months Hayward, California, United States Senior Scientist II, Preclinical Biology May 2022 - Jan 20239 months... Explore Rondo Therapeutics, Inc. with its drug pipeline, therapeutic area, technology platform, 4 news.Mar 15, 2023 · Rondo Therapeutics is part of the Business Services industry, and located in California, United States. Rondo Therapeutics Location San Francisco, California,United States Description Industry Medical Testing & Clinical Laboratories Healthcare Discover more about Rondo Therapeutics Todd Meyerrose Work Experience and Education Mar 2, 2022 · Funding Rounds 1 Total Funding Amount $67M Lead Investors 2 Investors 5 Funding Rondo Therapeutics has raised a total of $67M in funding over 1 round. This was a Series A round raised on Mar 2, 2022. Rondo Therapeutics is funded by 5 investors. SV Health Investors and Johnson & Johnson Innovation – JJDC are the most recent investors. Funding Rounds tarkett dalton ga Red Tree Venture Capital was founded in 2020 by Heath Lukatch, Ph.D., and Jennifer Cochran, Ph.D., two experienced life science industry veterans with deep connections to the West Coast academic and biopharma ecosystems.Mar 2, 2022 · The duo — who over 20 years have worked together at four companies, most recently at Newark's Teneobio Inc. — said Wednesday their latest company, Rondo Therapeutics of Alameda, landed fresh... Rondo Therapeutics 1 year 1 month Director, Preclinical biology Jan 2023 - Present5 months Hayward, California, United States Senior Scientist II, Preclinical Biology May 2022 - Jan 20239 months... Rondo Therapeutics | 941 followers on LinkedIn. Exploring new frontiers in cancer therapy. | At Rondo Therapeutics we believe that our success as a company starts with building a culture based on teamwork, trust, career growth, and a sense of fun. hf capital Rondo Therapeutics | 941 followers on LinkedIn. Exploring new frontiers in cancer therapy. | At Rondo Therapeutics we believe that our success as a company starts with building a culture based... Rondo Therapeutics raised $67000000 on 2022-03-02 in Series A. Red Tree Venture Capital Red Tree Venture Capital operates as a venture capital firm that focuses on entrepreneurs developing first-in-class. shenzhen electronics Rondo Therapeutics | 941 followers on LinkedIn. Exploring new frontiers in cancer therapy. | At Rondo Therapeutics we believe that our success as a company starts with building a culture based on teamwork, trust, career growth, and a sense of fun. sportsdataio Rondo Therapeutics Unknown Private Rondo Therapeutics is exploring new frontiers in cancer therapy. We are committed to advancing the field of immuno-oncology, with a focus on treating solid tumors that fail to respond to current therapies. Rondo's solution is to create a new class of bispecific antibodies that safely engage the immune system ...Rondo Therapeutics is a biopharmaceutical company exploring new frontiers in cancer therapy. Rondo is committed to advancing the field of immuno-oncology, with a focus on treating solid tumors that fail to respond to current therapies.Mar 2, 2022 · The duo — who over 20 years have worked together at four companies, most recently at Newark's Teneobio Inc. — said Wednesday their latest company, Rondo Therapeutics of Alameda, landed fresh... Rondo Therapeutics is a therapeutic antibody discovery and development that creates novel bispecific antibodies that activate the immune system to fight cancer. The company was founded in 2021 and is headquartered in Hayward, California. Industries Biotechnology, Health Care Headquarters Hayward, United States Stage Series A Employees 11-50 Links synergy funding group
Solutions from Rondo therapeutics, Inc. Yellow Pages directories can mean big success stories for your. rondo therapeutics White Pages are public records which are documents or pieces of information that are not considered confidential and can be viewed instantly online. me/rondo therapeutics If you're a small business in need of assistance, please contact [email protected]